PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
29735887-0	2018	Ursolic Acid Attenuates Atherosclerosis in ApoE-/- Mice: Role of LOX-1 Mediated by ROS/NF-kappaB Pathway.	ursolic acid	0-12	oxidized low density lipoprotein (lectin-like) receptor 1	Mus musculus	65-70	
29735887-6	2018	The evaluation in vitro suggested that UA significantly decreased endothelial LOX-1 expression induced by LPS both in mRNA and protein levels.	ursolic acid	39-41	oxidized low density lipoprotein (lectin-like) receptor 1	Mus musculus	78-83	
29735887-11	2018	The enhanced expression of LOX-1 in atherosclerotic aorta was also dramatically decreased by administration of UA.	ursolic acid	111-113	oxidized low density lipoprotein (lectin-like) receptor 1	Mus musculus	27-32	
29735887-12	2018	Taken together, these results suggested that UA, with anti-atherosclerotic activity through inhibition of LOX-1 mediated by ROS/NF-kappaB signaling pathways, may become a valuable vascular protective candidate for the treatment of atherosclerosis.	ursolic acid	45-47	oxidized low density lipoprotein (lectin-like) receptor 1	Mus musculus	106-111